If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 04/29/25
Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate AnalystsBenzinga • 04/29/25
Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder CancerBusiness Wire • 04/26/25
Exclusive: US pharma tariffs would raise US drug costs by $51 bln annually, report findsReuters • 04/25/25
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?Zacks Investment Research • 04/25/25
Curious about Pfizer (PFE) Q1 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 04/24/25
Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy PlatformBusiness Wire • 04/24/25
Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual MeetingBusiness Wire • 04/23/25